N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 14.82 CNY -0.74% Market Closed
Market Cap: 23.9B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Wall Street analysts forecast Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 21.51 CNY with a low forecast of 21.3 CNY and a high forecast of 22.14 CNY.

Lowest
Price Target
21.3 CNY
44% Upside
Average
Price Target
21.51 CNY
45% Upside
Highest
Price Target
22.14 CNY
49% Upside
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors:
Price Targets
4507
Shionogi & Co Ltd
16% Upside
002332
Zhejiang Xianju Pharmaceutical Co Ltd
30% Upside
AQST
Aquestive Therapeutics Inc
99% Upside
FULC
Fulcrum Therapeutics Inc
62% Upside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
37% Upside
CRON
Cronos Group Inc
22% Upside
GLS
Glenmark Life Sciences Ltd
2% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside

Revenue
Forecast

Revenue Estimate
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 22%.

30%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's stock price target?
Price Target
21.51 CNY

According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 21.51 CNY with a low forecast of 21.3 CNY and a high forecast of 22.14 CNY.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Nanjing King-friend Biochemical Pharmaceutical Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 22%.

Back to Top